ATE432473T1 - Peptide zur unterscheidung von prionen - Google Patents

Peptide zur unterscheidung von prionen

Info

Publication number
ATE432473T1
ATE432473T1 AT05256113T AT05256113T ATE432473T1 AT E432473 T1 ATE432473 T1 AT E432473T1 AT 05256113 T AT05256113 T AT 05256113T AT 05256113 T AT05256113 T AT 05256113T AT E432473 T1 ATE432473 T1 AT E432473T1
Authority
AT
Austria
Prior art keywords
prions
peptides
differentiation
Prior art date
Application number
AT05256113T
Other languages
English (en)
Inventor
Jian Zheng
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE432473T1 publication Critical patent/ATE432473T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05256113T 2004-09-30 2005-09-29 Peptide zur unterscheidung von prionen ATE432473T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61453304P 2004-09-30 2004-09-30

Publications (1)

Publication Number Publication Date
ATE432473T1 true ATE432473T1 (de) 2009-06-15

Family

ID=35432058

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09075234T ATE550666T1 (de) 2004-09-30 2005-09-29 Peptide zur unterscheidung von prionen
AT05256113T ATE432473T1 (de) 2004-09-30 2005-09-29 Peptide zur unterscheidung von prionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT09075234T ATE550666T1 (de) 2004-09-30 2005-09-29 Peptide zur unterscheidung von prionen

Country Status (14)

Country Link
EP (2) EP2085404B1 (de)
JP (1) JP4837353B2 (de)
KR (1) KR101355369B1 (de)
CN (1) CN1804628B (de)
AR (1) AR050965A1 (de)
AT (2) ATE550666T1 (de)
AU (1) AU2005209592B2 (de)
BR (1) BRPI0504220A (de)
CA (1) CA2518372C (de)
DE (1) DE602005014597D1 (de)
ES (2) ES2382935T3 (de)
HK (2) HK1088066A1 (de)
NZ (1) NZ542583A (de)
PT (2) PT2085404E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
AU2006287299B2 (en) 2005-09-09 2012-08-23 Novartis Ag Prion-specific peptoid reagents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806627A (en) 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
US5109464A (en) * 1991-05-24 1992-04-28 Amoco Corporation Rib waveguide optimized for low loss coupling to optical fibers and method of determining same
EP0861900A1 (de) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunologischer Nachweis von Prionen
US20010001061A1 (en) 1997-02-21 2001-05-10 Prusiner Stanley B. Assay for disease related conformation of a protein
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
EP1194164B8 (de) 1999-06-23 2007-03-21 IDEXX Laboratories Inc Prion protein peptide und deren verwendung
US6261790B1 (en) 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
EP1216258A1 (de) 1999-09-28 2002-06-26 Universität Zürich Faktoren mit prionen bindender aktivität im serum und plasma sowie mittel zur bestimmung von übertragbaren spongiformen encephalopathien
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
EP1294759A1 (de) 2000-06-26 2003-03-26 Universität Zürich Prionen-bindungsaktivtiät in serum und plasma bestimmt als plasminogen und fibrinogen
IL141950A0 (en) 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
US20020137114A1 (en) 2001-01-19 2002-09-26 Dirk Voelkel Method of detecting PrP protein and kits therefor
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
AU2003266801B2 (en) * 2002-12-19 2010-02-25 Ortho-Clinical Diagnostics, Inc Detection and diagnosis of transmissable spongiform encephalopathies

Also Published As

Publication number Publication date
EP1643252A3 (de) 2006-05-31
PT2085404E (pt) 2012-05-28
AU2005209592A1 (en) 2006-04-13
JP2006105988A (ja) 2006-04-20
CN1804628B (zh) 2012-03-14
HK1137764A1 (en) 2010-08-06
AU2005209592B2 (en) 2012-07-12
KR20060051862A (ko) 2006-05-19
DE602005014597D1 (de) 2009-07-09
EP1643252B1 (de) 2009-05-27
NZ542583A (en) 2007-02-23
ES2324919T3 (es) 2009-08-19
JP4837353B2 (ja) 2011-12-14
CN1804628A (zh) 2006-07-19
AR050965A1 (es) 2006-12-06
CA2518372C (en) 2013-07-09
CA2518372A1 (en) 2006-03-30
EP1643252A2 (de) 2006-04-05
EP2085404B1 (de) 2012-03-21
ES2382935T3 (es) 2012-06-14
KR101355369B1 (ko) 2014-02-03
BRPI0504220A (pt) 2006-05-16
PT1643252E (pt) 2009-06-30
EP2085404A1 (de) 2009-08-05
HK1088066A1 (en) 2006-10-27
ATE550666T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
ATE482281T1 (de) Plastiden transit peptide
HK1112847A1 (en) Self-assembling peptides for promoting hemostasis
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
BRPI0907363A2 (pt) Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
EP1909812A4 (de) Kleine verbindungen zur korrektur von protein-missfaltungen und verwendungen davon
GB0508863D0 (en) Peptide
DK1838341T3 (da) Vaccinesammensætning omfattende et fibronectin bindende protein eller et fibronectinbindende peptid
EP1909602A4 (de) Systeme und verfahren zum trennen von proteinen aus verbindungsgewebe
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE502005009697D1 (de) Depsipeptide zur verhinderung vertikaler endoparasiten-infektionen
ITMI20042353A1 (it) Peptidi per la veicolazione di farmaci
EP1845376A4 (de) Quantitatives messverfahren für rekombinantes protein
ATE432473T1 (de) Peptide zur unterscheidung von prionen
ATE445634T1 (de) Antimikrobielle peptide
ATE419271T1 (de) Antimikrobielle peptide
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
FI20040655A0 (fi) Proteiini- ja peptidistabilointi
GB0521490D0 (en) RFamide-related peptide precursor proteins and RFamide peptides
FI20061156A0 (fi) Uusia peptidejä
DK1935981T3 (da) Fremgangsmåde til fremstilling af rekombinant protein
GB0422110D0 (en) Recombinant proteins
ATE541926T1 (de) Neues zellpenetrierendes peptid
FI20055256A (fi) Luun proteiineja
FI20055258A0 (fi) Luun proteiineja

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties